From magic bullets to modern therapeutics: Paul Ehrlich, the German immunobiologist and physician coined the term ‘complement’

Paul Ehrlich was a pioneering Immunobiologist and physician who coined the term ‘complement’ in the year 1899. He was a leading visionary scientist who worked in the late 19th and early 20th centuries in Berlin and Frankfurt. He received numerous awards and honors for his substantial contributions t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular immunology 2022-10, Vol.150, p.90-98
Hauptverfasser: Zipfel, Peter F., Skerka, Christine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 98
container_issue
container_start_page 90
container_title Molecular immunology
container_volume 150
creator Zipfel, Peter F.
Skerka, Christine
description Paul Ehrlich was a pioneering Immunobiologist and physician who coined the term ‘complement’ in the year 1899. He was a leading visionary scientist who worked in the late 19th and early 20th centuries in Berlin and Frankfurt. He received numerous awards and honors for his substantial contributions to immunobiology and medicine, including the identification of complement, and he received the Nobel Prize in Physiology or Medicine in 1908 in recognition of his work on immunity. During his clinical work, Paul Ehrlich treated a patient with paroxysmal hemoglobinuria and reported his diagnostic approaches, including those related to erythrocyte lysis and microscopic cell analysis, to the Verein für Innere Medicine/Society of Internal Medicine, Berlin. Paroxysmal nocturnal hemoglobinuria was shown to be a complement-mediated disease; treatment of this disease with the complement inhibitor Eculzimab/Soliris was approved by the European Medicines Agency in 2003 and by the United States Food and Drug Administration in 2007. •Paul Ehrlich a pioneering Immunobiologist and physician received the Nobel Prize in Physiology or Medicine in 1908.•He is the first person who published the term complement in 1899.•Paul Ehrlich collaborated with other prominent scientist of his time and Nobel Laureates Robert Koch and Emil von Behring.
doi_str_mv 10.1016/j.molimm.2022.08.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2707598753</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0161589022003911</els_id><sourcerecordid>2707598753</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-5a28a960df95e0095b417890d993f2c4507c4fee89f68172353d89e6209702713</originalsourceid><addsrcrecordid>eNp9kMFu1DAURaMKJIaWP2DhZRckfXbiOGaBhKq2VKpEF7C2PM5LxyM7DraD1F3Vr4Df65fgYVizeot77n26t6reU2go0P5i3_jgrPcNA8YaGBoAdlJt6CBYLWnHXlWbgtGaDxLeVG9T2gNADz3fVM_XMXji9YM1ZLs6hzmRHIgPI8aZ5B1GveCarUkfyb1eHbnaRWfN7sNBIzcYvZ5Jeb3OYWuDCw82ZaLnkSy7x2SNLaoJdsbxL58LT16efpngF4ce5_zy9Pusej1pl_Ddv3tafb---nb5pb77enN7-fmuNi3lueaaDVr2ME6SI4Dk246KUmiUsp2Y6TgI002Ig5z6gQrW8nYcJPYMpAAmaHtanR9zlxh-rJiy8jYZdE7PGNakmADB5SB4W9DuiJoYUoo4qSVar-OjoqAOk6u9Ok6uDpMrGFSZvNg-HW1Yavy0GFUyFmeDo41oshqD_X_AH6r8jvc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2707598753</pqid></control><display><type>article</type><title>From magic bullets to modern therapeutics: Paul Ehrlich, the German immunobiologist and physician coined the term ‘complement’</title><source>Access via ScienceDirect (Elsevier)</source><creator>Zipfel, Peter F. ; Skerka, Christine</creator><creatorcontrib>Zipfel, Peter F. ; Skerka, Christine</creatorcontrib><description>Paul Ehrlich was a pioneering Immunobiologist and physician who coined the term ‘complement’ in the year 1899. He was a leading visionary scientist who worked in the late 19th and early 20th centuries in Berlin and Frankfurt. He received numerous awards and honors for his substantial contributions to immunobiology and medicine, including the identification of complement, and he received the Nobel Prize in Physiology or Medicine in 1908 in recognition of his work on immunity. During his clinical work, Paul Ehrlich treated a patient with paroxysmal hemoglobinuria and reported his diagnostic approaches, including those related to erythrocyte lysis and microscopic cell analysis, to the Verein für Innere Medicine/Society of Internal Medicine, Berlin. Paroxysmal nocturnal hemoglobinuria was shown to be a complement-mediated disease; treatment of this disease with the complement inhibitor Eculzimab/Soliris was approved by the European Medicines Agency in 2003 and by the United States Food and Drug Administration in 2007. •Paul Ehrlich a pioneering Immunobiologist and physician received the Nobel Prize in Physiology or Medicine in 1908.•He is the first person who published the term complement in 1899.•Paul Ehrlich collaborated with other prominent scientist of his time and Nobel Laureates Robert Koch and Emil von Behring.</description><identifier>ISSN: 0161-5890</identifier><identifier>EISSN: 1872-9142</identifier><identifier>DOI: 10.1016/j.molimm.2022.08.002</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>Bacteriolysis ; Complement ; Hemolysis ; Innate Immunity ; Microbial Lysis ; Nobel Prize ; Paul Ehrlich</subject><ispartof>Molecular immunology, 2022-10, Vol.150, p.90-98</ispartof><rights>2022 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-5a28a960df95e0095b417890d993f2c4507c4fee89f68172353d89e6209702713</citedby><cites>FETCH-LOGICAL-c315t-5a28a960df95e0095b417890d993f2c4507c4fee89f68172353d89e6209702713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.molimm.2022.08.002$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Zipfel, Peter F.</creatorcontrib><creatorcontrib>Skerka, Christine</creatorcontrib><title>From magic bullets to modern therapeutics: Paul Ehrlich, the German immunobiologist and physician coined the term ‘complement’</title><title>Molecular immunology</title><description>Paul Ehrlich was a pioneering Immunobiologist and physician who coined the term ‘complement’ in the year 1899. He was a leading visionary scientist who worked in the late 19th and early 20th centuries in Berlin and Frankfurt. He received numerous awards and honors for his substantial contributions to immunobiology and medicine, including the identification of complement, and he received the Nobel Prize in Physiology or Medicine in 1908 in recognition of his work on immunity. During his clinical work, Paul Ehrlich treated a patient with paroxysmal hemoglobinuria and reported his diagnostic approaches, including those related to erythrocyte lysis and microscopic cell analysis, to the Verein für Innere Medicine/Society of Internal Medicine, Berlin. Paroxysmal nocturnal hemoglobinuria was shown to be a complement-mediated disease; treatment of this disease with the complement inhibitor Eculzimab/Soliris was approved by the European Medicines Agency in 2003 and by the United States Food and Drug Administration in 2007. •Paul Ehrlich a pioneering Immunobiologist and physician received the Nobel Prize in Physiology or Medicine in 1908.•He is the first person who published the term complement in 1899.•Paul Ehrlich collaborated with other prominent scientist of his time and Nobel Laureates Robert Koch and Emil von Behring.</description><subject>Bacteriolysis</subject><subject>Complement</subject><subject>Hemolysis</subject><subject>Innate Immunity</subject><subject>Microbial Lysis</subject><subject>Nobel Prize</subject><subject>Paul Ehrlich</subject><issn>0161-5890</issn><issn>1872-9142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kMFu1DAURaMKJIaWP2DhZRckfXbiOGaBhKq2VKpEF7C2PM5LxyM7DraD1F3Vr4Df65fgYVizeot77n26t6reU2go0P5i3_jgrPcNA8YaGBoAdlJt6CBYLWnHXlWbgtGaDxLeVG9T2gNADz3fVM_XMXji9YM1ZLs6hzmRHIgPI8aZ5B1GveCarUkfyb1eHbnaRWfN7sNBIzcYvZ5Jeb3OYWuDCw82ZaLnkSy7x2SNLaoJdsbxL58LT16efpngF4ce5_zy9Pusej1pl_Ddv3tafb---nb5pb77enN7-fmuNi3lueaaDVr2ME6SI4Dk246KUmiUsp2Y6TgI002Ig5z6gQrW8nYcJPYMpAAmaHtanR9zlxh-rJiy8jYZdE7PGNakmADB5SB4W9DuiJoYUoo4qSVar-OjoqAOk6u9Ok6uDpMrGFSZvNg-HW1Yavy0GFUyFmeDo41oshqD_X_AH6r8jvc</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Zipfel, Peter F.</creator><creator>Skerka, Christine</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202210</creationdate><title>From magic bullets to modern therapeutics: Paul Ehrlich, the German immunobiologist and physician coined the term ‘complement’</title><author>Zipfel, Peter F. ; Skerka, Christine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-5a28a960df95e0095b417890d993f2c4507c4fee89f68172353d89e6209702713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bacteriolysis</topic><topic>Complement</topic><topic>Hemolysis</topic><topic>Innate Immunity</topic><topic>Microbial Lysis</topic><topic>Nobel Prize</topic><topic>Paul Ehrlich</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zipfel, Peter F.</creatorcontrib><creatorcontrib>Skerka, Christine</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zipfel, Peter F.</au><au>Skerka, Christine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>From magic bullets to modern therapeutics: Paul Ehrlich, the German immunobiologist and physician coined the term ‘complement’</atitle><jtitle>Molecular immunology</jtitle><date>2022-10</date><risdate>2022</risdate><volume>150</volume><spage>90</spage><epage>98</epage><pages>90-98</pages><issn>0161-5890</issn><eissn>1872-9142</eissn><abstract>Paul Ehrlich was a pioneering Immunobiologist and physician who coined the term ‘complement’ in the year 1899. He was a leading visionary scientist who worked in the late 19th and early 20th centuries in Berlin and Frankfurt. He received numerous awards and honors for his substantial contributions to immunobiology and medicine, including the identification of complement, and he received the Nobel Prize in Physiology or Medicine in 1908 in recognition of his work on immunity. During his clinical work, Paul Ehrlich treated a patient with paroxysmal hemoglobinuria and reported his diagnostic approaches, including those related to erythrocyte lysis and microscopic cell analysis, to the Verein für Innere Medicine/Society of Internal Medicine, Berlin. Paroxysmal nocturnal hemoglobinuria was shown to be a complement-mediated disease; treatment of this disease with the complement inhibitor Eculzimab/Soliris was approved by the European Medicines Agency in 2003 and by the United States Food and Drug Administration in 2007. •Paul Ehrlich a pioneering Immunobiologist and physician received the Nobel Prize in Physiology or Medicine in 1908.•He is the first person who published the term complement in 1899.•Paul Ehrlich collaborated with other prominent scientist of his time and Nobel Laureates Robert Koch and Emil von Behring.</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.molimm.2022.08.002</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0161-5890
ispartof Molecular immunology, 2022-10, Vol.150, p.90-98
issn 0161-5890
1872-9142
language eng
recordid cdi_proquest_miscellaneous_2707598753
source Access via ScienceDirect (Elsevier)
subjects Bacteriolysis
Complement
Hemolysis
Innate Immunity
Microbial Lysis
Nobel Prize
Paul Ehrlich
title From magic bullets to modern therapeutics: Paul Ehrlich, the German immunobiologist and physician coined the term ‘complement’
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T04%3A04%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=From%20magic%20bullets%20to%20modern%20therapeutics:%20Paul%20Ehrlich,%20the%20German%20immunobiologist%20and%20physician%20coined%20the%20term%20%E2%80%98complement%E2%80%99&rft.jtitle=Molecular%20immunology&rft.au=Zipfel,%20Peter%20F.&rft.date=2022-10&rft.volume=150&rft.spage=90&rft.epage=98&rft.pages=90-98&rft.issn=0161-5890&rft.eissn=1872-9142&rft_id=info:doi/10.1016/j.molimm.2022.08.002&rft_dat=%3Cproquest_cross%3E2707598753%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2707598753&rft_id=info:pmid/&rft_els_id=S0161589022003911&rfr_iscdi=true